Goyanes Á - Search Results

1

3D printing for the development of implantable devices for cardiovascular disease treatment.

Larrañeta E, Domínguez-Robles J, Margariti A, Basit AW, Goyanes Á. Larrañeta E, et al. Among authors: goyanes a. Ther Deliv. 2022 Jul;13(7):359-362. doi: 10.4155/tde-2022-0017. Epub 2022 Aug 24. Ther Deliv. 2022. PMID: 36000225 No abstract available.

2

Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.

Varum FJ, Merchant HA, Goyanes A, Assi P, Zboranová V, Basit AW. Varum FJ, et al. Among authors: goyanes a. Int J Pharm. 2014 Jul 1;468(1-2):172-7. doi: 10.1016/j.ijpharm.2014.04.019. Epub 2014 Apr 13. Int J Pharm. 2014. PMID: 24727141

3

Predicting the gastrointestinal behaviour of modified-release products: utility of a novel dynamic dissolution test apparatus involving the use of bicarbonate buffers.

Merchant HA, Goyanes A, Parashar N, Basit AW. Merchant HA, et al. Among authors: goyanes a. Int J Pharm. 2014 Nov 20;475(1-2):585-91. doi: 10.1016/j.ijpharm.2014.09.003. Epub 2014 Sep 6. Int J Pharm. 2014. PMID: 25195730

4

Fused-filament 3D printing (3DP) for fabrication of tablets.

Goyanes A, Buanz AB, Basit AW, Gaisford S. Goyanes A, et al. Int J Pharm. 2014 Dec 10;476(1-2):88-92. doi: 10.1016/j.ijpharm.2014.09.044. Epub 2014 Sep 30. Int J Pharm. 2014. PMID: 25275937

5

3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets.

Goyanes A, Buanz AB, Hatton GB, Gaisford S, Basit AW. Goyanes A, et al. Eur J Pharm Biopharm. 2015 Jan;89:157-62. doi: 10.1016/j.ejpb.2014.12.003. Epub 2014 Dec 9. Eur J Pharm Biopharm. 2015. PMID: 25497178 Free article.

6

Gastrointestinal release behaviour of modified-release drug products: dynamic dissolution testing of mesalazine formulations.

Goyanes A, Hatton GB, Merchant HA, Basit AW. Goyanes A, et al. Int J Pharm. 2015 Apr 30;484(1-2):103-8. doi: 10.1016/j.ijpharm.2015.02.051. Epub 2015 Feb 23. Int J Pharm. 2015. PMID: 25721685

7

Effect of geometry on drug release from 3D printed tablets.

Goyanes A, Robles Martinez P, Buanz A, Basit AW, Gaisford S. Goyanes A, et al. Int J Pharm. 2015 Oct 30;494(2):657-663. doi: 10.1016/j.ijpharm.2015.04.069. Epub 2015 Apr 28. Int J Pharm. 2015. PMID: 25934428

8

3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics.

Goyanes A, Wang J, Buanz A, Martínez-Pacheco R, Telford R, Gaisford S, Basit AW. Goyanes A, et al. Mol Pharm. 2015 Nov 2;12(11):4077-84. doi: 10.1021/acs.molpharmaceut.5b00510. Epub 2015 Oct 16. Mol Pharm. 2015. PMID: 26473653

9

Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing.

Goyanes A, Chang H, Sedough D, Hatton GB, Wang J, Buanz A, Gaisford S, Basit AW. Goyanes A, et al. Int J Pharm. 2015 Dec 30;496(2):414-20. doi: 10.1016/j.ijpharm.2015.10.039. Epub 2015 Oct 19. Int J Pharm. 2015. PMID: 26481468

10

Stereolithographic (SLA) 3D printing of oral modified-release dosage forms.

Wang J, Goyanes A, Gaisford S, Basit AW. Wang J, et al. Among authors: goyanes a. Int J Pharm. 2016 Apr 30;503(1-2):207-12. doi: 10.1016/j.ijpharm.2016.03.016. Epub 2016 Mar 11. Int J Pharm. 2016. PMID: 26976500

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters